Vitalone Britt J., EVP & CFO, has demonstrated a consistent pattern of selling activity across two companies—primarily McKesson Corporation (MCK) and, to a lesser extent, Align Technology (ALGN)—with no recorded purchases in the available data. Over 25 reported transactions, all were sales, totaling approximately $24.8 million in value. The bulk of this activity has been concentrated in MCK, with notable sales including a $4.5 million transaction on May 22, 2025, and a $7.1 million sale on May 23, 2024. Smaller but repeated dispositions, such as a $523,556 sale on May 23, 2025, and a $498,316 sale on May 28, 2024, suggest an ongoing divestment strategy rather than a one-time liquidation.
Recent filings indicate an acceleration in selling, with six transactions in 2025 alone, all involving MCK. These include a $1.35 million sale on May 28, 2025, and multiple smaller transactions tied to derivative holdings (coded "F" for tax withholding or "M" for gift transfers). The absence of any buys—coupled with the recurring nature of the sales—points to a clear directional bias toward reducing exposure. While ALGN appears in the filings, the activity is limited to a single transaction in July 2025 with no reported value, leaving MCK as the focal point of Vitalone’s divestment. The pattern aligns with executives periodically unwinding equity positions, though the scale and frequency suggest a deliberate reduction in holdings over time.
AI-assisted summary